{
    "id": "c1808df466",
    "abstract": [],
    "body_text": [
        {
            "text": "One of the strategies to repair and regenerate damaged or diseased soft tissues is extracellular matrix (ECM)-induced in situ tissue formation that leads to the restoration and improvement of functions of affected tissues and organs. ",
            "section": "Introduction"
        },
        {
            "text": "The pathway involves ECM preparation, implantation, host cell repopulation, revascularization, and remodeling of ECM scaffold. ",
            "section": "Introduction"
        },
        {
            "text": "ECM scaffolds contain many structural proteins with proper extracellular architecture, and signaling molecules such as fibronectin, integrins, laminin, and sequestered growth factors. ",
            "section": "Introduction"
        },
        {
            "text": "The implanted ECM scaffold provides biomechanical support and can elicit new tissue formation by interacting with host cells to modulate cell behaviors such as adhesion, migration, proliferation, and differentiation, as well as to modulate inflammatory responses and remodeling of ECM scaffolds. ",
            "section": "Introduction"
        },
        {
            "text": "[1][2][3][4][5][6] Presently, about 30 tissue-derived scaffold products have received approval from United States and European regulatory authorities, and are marketed for various clinical applications in tissue repair and regeneration, 3,[7][8][9] with 2011 US sales alone exceeding US$1 billion. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 3,
                    "type": "bibr",
                    "ref_id": "b0",
                    "text": "[1]"
                },
                {
                    "start": 3,
                    "end": 6,
                    "type": "bibr",
                    "ref_id": "b1",
                    "text": "[2]"
                },
                {
                    "start": 6,
                    "end": 9,
                    "type": "bibr",
                    "ref_id": "b2",
                    "text": "[3]"
                },
                {
                    "start": 9,
                    "end": 12,
                    "type": "bibr",
                    "ref_id": "b3",
                    "text": "[4]"
                },
                {
                    "start": 12,
                    "end": 15,
                    "type": "bibr",
                    "ref_id": "b4",
                    "text": "[5]"
                },
                {
                    "start": 15,
                    "end": 18,
                    "type": "bibr",
                    "ref_id": "b5",
                    "text": "[6]"
                },
                {
                    "start": 237,
                    "end": 239,
                    "type": "bibr",
                    "ref_id": "b2",
                    "text": "3,"
                },
                {
                    "start": 239,
                    "end": 242,
                    "type": "bibr",
                    "ref_id": "b6",
                    "text": "[7]"
                },
                {
                    "start": 242,
                    "end": 245,
                    "type": "bibr",
                    "ref_id": "b7",
                    "text": "[8]"
                },
                {
                    "start": 245,
                    "end": 248,
                    "type": "bibr",
                    "ref_id": "b8",
                    "text": "[9]"
                }
            ]
        },
        {
            "text": "10 These scaffolds are derived from a variety of human and mammalian tissues, including blood vessel, heart valve, ligament, nerve, skin, small intestinal submucosa, forestomach, pericardium, peritoneum, tendons, and urinary bladder. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 2,
                    "type": "bibr",
                    "ref_id": "b9",
                    "text": "10"
                }
            ]
        },
        {
            "text": "ECM-based scaffolds are the first wave of commercially available products for tissue engineering and regenerative medicine, and have achieved considerable success satisfying unmet clinical needs. ",
            "section": "Introduction"
        },
        {
            "text": "This approach has been used to reconstruct and to repair increasingly more complex tissues and organs in human patients, 11,12 and may be a promising platform for engineering whole functional organs by using in vitro recelluarization and matrix remodeling with autologous stem cells or differentiated cells. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 121,
                    "end": 124,
                    "type": "bibr",
                    "ref_id": "b10",
                    "text": "11,"
                },
                {
                    "start": 124,
                    "end": 126,
                    "type": "bibr",
                    "ref_id": "b11",
                    "text": "12"
                }
            ]
        },
        {
            "text": "13 When an ECM scaffold is derived from donated human or other mammalian tissues, the native ECM is subjected to biochemical and structural alterations during processing that involves chemical, enzymatic, or physical decellularization, antigenicity reduction treatment, viral inactivation, and terminal sterilization. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 2,
                    "type": "bibr",
                    "ref_id": "b12",
                    "text": "13"
                }
            ]
        },
        {
            "text": "Different processing methods are known to yield ECM materials with different structural and biological properties. ",
            "section": "Introduction"
        },
        {
            "text": "9,[14][15][16][17][18] Preclinical and clinical evidences demonstrate that not all biologically derived scaffolds are equal and that host responses in tissue regeneration vary among scaffold products. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 2,
                    "type": "bibr",
                    "ref_id": "b8",
                    "text": "9,"
                },
                {
                    "start": 2,
                    "end": 6,
                    "type": "bibr",
                    "ref_id": "b13",
                    "text": "[14]"
                },
                {
                    "start": 6,
                    "end": 10,
                    "type": "bibr",
                    "ref_id": "b14",
                    "text": "[15]"
                },
                {
                    "start": 10,
                    "end": 14,
                    "type": "bibr",
                    "ref_id": "b15",
                    "text": "[16]"
                },
                {
                    "start": 14,
                    "end": 18,
                    "type": "bibr",
                    "ref_id": "b16",
                    "text": "[17]"
                },
                {
                    "start": 18,
                    "end": 22,
                    "type": "bibr",
                    "ref_id": "b17",
                    "text": "[18]"
                }
            ]
        },
        {
            "text": "8,[19][20][21][22][23][24][25][26] The variation of performance in tissue repair and regeneration among scaffolds is presumably due to different tissue sources, the presence of undesirable cellular and matrix elements, and matrix damage or modifications upon tissue processing. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 2,
                    "type": "bibr",
                    "ref_id": "b7",
                    "text": "8,"
                },
                {
                    "start": 2,
                    "end": 6,
                    "type": "bibr",
                    "ref_id": "b18",
                    "text": "[19]"
                },
                {
                    "start": 6,
                    "end": 10,
                    "type": "bibr",
                    "ref_id": "b19",
                    "text": "[20]"
                },
                {
                    "start": 10,
                    "end": 14,
                    "type": "bibr",
                    "ref_id": "b20",
                    "text": "[21]"
                },
                {
                    "start": 14,
                    "end": 18,
                    "type": "bibr",
                    "ref_id": "b21",
                    "text": "[22]"
                },
                {
                    "start": 18,
                    "end": 22,
                    "type": "bibr",
                    "ref_id": "b22",
                    "text": "[23]"
                },
                {
                    "start": 22,
                    "end": 26,
                    "type": "bibr",
                    "ref_id": "b23",
                    "text": "[24]"
                },
                {
                    "start": 26,
                    "end": 30,
                    "type": "bibr",
                    "ref_id": "b24",
                    "text": "[25]"
                },
                {
                    "start": 30,
                    "end": 34,
                    "type": "bibr",
                    "ref_id": "b25",
                    "text": "[26]"
                }
            ]
        },
        {
            "text": "2,7,9,15,20,22,23,[26][27][28] However, there are no generally accepted performance specifications for biological scaffolds, and little information is available about ECM modifications among commercially available scaffold products. ",
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 2,
                    "type": "bibr",
                    "ref_id": "b1",
                    "text": "2,"
                },
                {
                    "start": 2,
                    "end": 4,
                    "type": "bibr",
                    "ref_id": "b6",
                    "text": "7,"
                },
                {
                    "start": 4,
                    "end": 6,
                    "type": "bibr",
                    "ref_id": "b8",
                    "text": "9,"
                },
                {
                    "start": 6,
                    "end": 9,
                    "type": "bibr",
                    "ref_id": "b14",
                    "text": "15,"
                },
                {
                    "start": 9,
                    "end": 12,
                    "type": "bibr",
                    "ref_id": "b19",
                    "text": "20,"
                },
                {
                    "start": 12,
                    "end": 15,
                    "type": "bibr",
                    "ref_id": "b21",
                    "text": "22,"
                },
                {
                    "start": 15,
                    "end": 18,
                    "type": "bibr",
                    "ref_id": "b22",
                    "text": "23,"
                },
                {
                    "start": 18,
                    "end": 22,
                    "type": "bibr",
                    "ref_id": "b25",
                    "text": "[26]"
                },
                {
                    "start": 22,
                    "end": 26,
                    "type": "bibr",
                    "ref_id": "b26",
                    "text": "[27]"
                },
                {
                    "start": 26,
                    "end": 30,
                    "type": "bibr",
                    "ref_id": "b27",
                    "text": "[28]"
                }
            ]
        },
        {
            "text": "How the process-induced ECM modifications affect the mechanisms of action in tissue repair remains poorly understood.",
            "section": "Introduction"
        },
        {
            "text": "To gain insight into the rational design of tissue engineering scaffolds, this study has examined ECM modifications in three non-cross-linked, commercially available scaffolds (Strattice \u2122 reconstructive tissue matrix, Veritas \u00ae collagen matrix, and XenMatrix \u2122 surgical graft). ",
            "section": "Introduction"
        },
        {
            "text": "It aims to correlate the comparative differences in ECM modifications among three scaffolds to biological responses in tissue repair and regeneration after implantation in a primate model. ",
            "section": "Introduction"
        },
        {
            "text": "The comparative investigation of commercially available scaffolds may offer valuable biochemical and structural insights into the rational design of tissue engineering scaffolds.",
            "section": "Introduction"
        },
        {
            "text": "A part of the research project involves the use of nonhuman primate subjects. ",
            "section": "Ethics statements"
        },
        {
            "text": "The non-human primate study was performed in strict compliance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health, and all appropriate parts of the Animal Welfare Act of 1966 (P.L. 89-544), as amended by the Animal Welfare Act of 1970 (P.L. 91-579) and the 1976 amendments to the Animal Welfare Act (P.L. 94-279)-9 Code of Federal Regulations (CFR) Chapter I (1 January 1998 edition) as well as the International Guiding Principles for Biomedical Research Involving Animals developed by the Council for International Organizations of Medical Sciences and the following guidelines for animal welfare. ",
            "section": "Ethics statements",
            "entity_spans": [
                {
                    "type": "software",
                    "start": 95,
                    "end": 100,
                    "rawForm": "Guide",
                    "resp": "whitelist",
                    "id": "c1808df466-software-simple-w0"
                }
            ]
        },
        {
            "text": "The study protocol was reviewed and approved by the Institutional Animal Care and Use Committee (IACUC), the Behavioral Sciences Foundation (St Kitts, Eastern Caribbean). ",
            "section": "Ethics statements",
            "entity_spans": [
                {
                    "type": "software",
                    "start": 129,
                    "end": 139,
                    "rawForm": "Foundation",
                    "resp": "whitelist",
                    "id": "c1808df466-software-simple-w1"
                }
            ]
        },
        {
            "text": "The research facility of the Behavioral Sciences Foundation is accredited by the Canadian Council for Animal Care and has a Public Health Service (PHS)-approved Animal Welfare Assurance (A5535-01) issued by the Office of Laboratory Animal Welfare (OLAW).",
            "section": "Ethics statements",
            "entity_spans": [
                {
                    "type": "software",
                    "start": 49,
                    "end": 59,
                    "rawForm": "Foundation",
                    "resp": "whitelist",
                    "id": "c1808df466-software-simple-w2"
                },
                {
                    "type": "software",
                    "start": 138,
                    "end": 145,
                    "rawForm": "Service",
                    "resp": "whitelist",
                    "id": "c1808df466-software-simple-w3"
                },
                {
                    "type": "software",
                    "start": 211,
                    "end": 217,
                    "rawForm": "Office",
                    "resp": "whitelist",
                    "id": "c1808df466-software-simple-w4"
                }
            ]
        },
        {
            "text": "Strattice reconstructive tissue matrix (LifeCell Corporation, Branchburg, NJ) is derived from porcine dermis with a process that removes cellular elements and reduces \u03b1-gal epitope in ECM via enzymatic cleavage. ",
            "section": "Tissue-based biological scaffolds"
        },
        {
            "text": "Viral reduction and e-beam irradiation are applied to yield a sterile scaffold that retains structural and biochemical integrity of porcine dermis ECM. ",
            "section": "Tissue-based biological scaffolds"
        },
        {
            "text": "22,29 Veritas collagen matrix (Synovis Life Technologies, St Paul, MN) is derived from bovine pericardium. ",
            "section": "Tissue-based biological scaffolds",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 3,
                    "type": "bibr",
                    "ref_id": "b21",
                    "text": "22,"
                },
                {
                    "start": 3,
                    "end": 5,
                    "type": "bibr",
                    "ref_id": "b28",
                    "text": "29"
                }
            ]
        },
        {
            "text": "Pericardium is decellularized and exposed to 1.0 N sodium hydroxide to eliminate bovine spongiform encephalopathy (BSE) transmission. ",
            "section": "Tissue-based biological scaffolds"
        },
        {
            "text": "The decellularized pericardium is then treated with propylene oxide for capping primary amine groups to reduce immunogenicity. ",
            "section": "Tissue-based biological scaffolds"
        },
        {
            "text": "Veritas is terminally sterilized by e-beam irradiation. ",
            "section": "Tissue-based biological scaffolds"
        },
        {
            "text": "[30][31][32] XenMatrix surgical graft (Davol, Inc., Warwick, RI) is also derived from porcine dermis, which is treated by a proprietary processing technology to achieve an open matrix structure designed to encourage cell repopulation and minimize encapsulation by fibrotic tissue. ",
            "section": "Tissue-based biological scaffolds",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 4,
                    "type": "bibr",
                    "ref_id": "b29",
                    "text": "[30]"
                },
                {
                    "start": 4,
                    "end": 8,
                    "type": "bibr",
                    "ref_id": "b30",
                    "text": "[31]"
                },
                {
                    "start": 8,
                    "end": 12,
                    "type": "bibr",
                    "ref_id": "b31",
                    "text": "[32]"
                }
            ]
        },
        {
            "text": "33 The XenMatrix process involves ",
            "section": "Tissue-based biological scaffolds",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 2,
                    "type": "bibr",
                    "ref_id": "b32",
                    "text": "33"
                }
            ]
        },
        {
            "text": "(a) freezing, thawing, and bleaching of porcine dermis to loosen the collagen matrix; ",
            "section": "Tissue-based biological scaffolds"
        },
        {
            "text": "(b) removing noncollagenous elements; and ",
            "section": "Tissue-based biological scaffolds"
        },
        {
            "text": "(c) treating with sodium hydroxide solution and hydrogen peroxide solution to improve biocompatibility. ",
            "section": "Tissue-based biological scaffolds"
        },
        {
            "text": "34 XenMatrix graft is sterilized by e-beam irradiation. ",
            "section": "Tissue-based biological scaffolds",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 2,
                    "type": "bibr",
                    "ref_id": "b33",
                    "text": "34"
                }
            ]
        },
        {
            "text": "All three products are packaged in the hydrated state, and labeled as being non-cross-linked and stable for room temperature storage. ",
            "section": "Tissue-based biological scaffolds"
        },
        {
            "text": "These scaffolds are increasingly utilized to support soft tissue regeneration, including applications in hernia repairs, and urological, gynecological, and breast reconstruction surgeries. ",
            "section": "Tissue-based biological scaffolds"
        },
        {
            "text": "8,[35][36][37] ",
            "section": "Tissue-based biological scaffolds",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 2,
                    "type": "bibr",
                    "ref_id": "b7",
                    "text": "8,"
                },
                {
                    "start": 2,
                    "end": 6,
                    "type": "bibr",
                    "ref_id": "b34",
                    "text": "[35]"
                },
                {
                    "start": 6,
                    "end": 10,
                    "type": "bibr",
                    "ref_id": "b35",
                    "text": "[36]"
                },
                {
                    "start": 10,
                    "end": 14,
                    "type": "bibr",
                    "ref_id": "b36",
                    "text": "[37]"
                }
            ]
        },
        {
            "text": "To evaluate the extent of ECM modifications in commercially available scaffolds, minimally processed porcine dermis ECM (pd-ECM) and bovine pericardium ECM (bp-ECM) were derived from freshly slaughtered animals to serve as controls. ",
            "section": "Minimally processed ECM materials"
        },
        {
            "text": "Porcine skin from 6-month-old animals and bovine pericardium from 18-to 24-month-old animals were cleaned manually to remove hairs, epidermis, and adipose tissue. ",
            "section": "Minimally processed ECM materials"
        },
        {
            "text": "Isolated dermis (\u02dc1.0 mm thick) and pericardium (\u02dc0.4-0.7 mm thick) were aseptically decellularized in 2% (w/v) sodium deoxycholate in 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (pH 8.0) containing 10 mM ethylenediaminetetraacetic acid (EDTA). ",
            "section": "Minimally processed ECM materials"
        },
        {
            "text": "Decellularization was carried out with gentle agitation for 8 h at 22\u00b0C-24\u00b0C, and decellularized ECMs were washed in Dulbecco's phosphatebuffered saline (PBS; pH 7.2) three times over a period of 18 h. ",
            "section": "Minimally processed ECM materials"
        },
        {
            "text": "The minimally processed tissue ECMs were temporarily stored in PBS at 4\u00b0C, and were used for testing within a week.",
            "section": "Minimally processed ECM materials"
        },
        {
            "text": "For histological analysis, samples of ECM materials were rinsed in 0.9% saline for 1 h before fixation in 10% buffered formalin solution. ",
            "section": "Histological and scanning electron microscopic evaluation"
        },
        {
            "text": "Samples were routinely processed through dehydration, embedment in paraffin, and sectioning. ",
            "section": "Histological and scanning electron microscopic evaluation"
        },
        {
            "text": "Tissue slices were stained with hematoxylin-eosin (H&E) stain. ",
            "section": "Histological and scanning electron microscopic evaluation"
        },
        {
            "text": "For scanning electron microscope (SEM) evaluation, tissue samples were fixed in 2% glutaraldehyde, cut to the desired size, and dehydrated through a series of ethanol solutions with increasing concentrations from 50% to 100%. ",
            "section": "Histological and scanning electron microscopic evaluation"
        },
        {
            "text": "Specimens in 100% ethanol were gradually changed to 100% hexamethyldisilazane for drying. ",
            "section": "Histological and scanning electron microscopic evaluation"
        },
        {
            "text": "Dried specimens were mounted and coated with gold palladium under vacuum (<8 Pa) for 120 s. ",
            "section": "Histological and scanning electron microscopic evaluation"
        },
        {
            "text": "The microstructures of samples were viewed, and micrographs were captured using a desktop SEM (NeoScope JCM-5000; Jeol Ltd, Tokyo, Japan) at 10 kV.",
            "section": "Histological and scanning electron microscopic evaluation"
        },
        {
            "text": "Samples of ECM materials were rinsed in Dulbecco's PBS (pH 7.4). ",
            "section": "Calorimetric analysis"
        },
        {
            "text": "Samples (25-30 mg) were hermetically sealed in aluminum crucibles. ",
            "section": "Calorimetric analysis",
            "ref_spans": [
                {
                    "start": 8,
                    "end": 18,
                    "type": "bibr",
                    "text": "(25-30 mg)"
                }
            ]
        },
        {
            "text": "Thermograms were recorded using differential scanning calorimeter (Model Q2000; TA Instruments, New Castle, DE) from 2\u00b0C to 125\u00b0C at various heating rates between 0.02\u00b0C/min and 50\u00b0C/min. ",
            "section": "Calorimetric analysis"
        },
        {
            "text": "After calorimetric measurement, small holes were punched on sealed crucibles with a pin, and the dry mass of samples was measured after dehydration between 105\u00b0C and 110\u00b0C under vacuum overnight. ",
            "section": "Calorimetric analysis"
        },
        {
            "text": "Thermograms were analyzed using the software Universal Analysis 2000 (version 4.5) to determine the onset temperature (T d ) and enthalpy (\u0394\u0397) of collagen denaturation.",
            "section": "Calorimetric analysis",
            "entity_spans": [
                {
                    "start": 45,
                    "end": 68,
                    "type": "software",
                    "rawForm": "Universal Analysis 2000",
                    "resp": "#annotator4",
                    "used": true,
                    "id": "c1808df466-software-0"
                },
                {
                    "start": 78,
                    "end": 81,
                    "type": "version",
                    "rawForm": "4.5",
                    "resp": "#annotator4",
                    "id": "#c1808df466-software-0"
                },
                {
                    "type": "software",
                    "start": 36,
                    "end": 44,
                    "rawForm": "software",
                    "resp": "whitelist",
                    "id": "c1808df466-software-simple-w5"
                }
            ]
        },
        {
            "text": "The susceptibility of ECM materials to type I collagenase (Sigma-Aldrich, St Louis, MO) was tested at 37\u00b0C in vitro. ",
            "section": "Collagenase susceptibility assay"
        },
        {
            "text": "Samples were rinsed in 0.9% saline, 60-80 mg material was placed in 2.0-mL Eppendorf tubes, and 1.5 mL of pre-warmed 10 mM Tris-HCl buffer containing 2 mM CaCl 2 (pH 7.5) was added to each sample. ",
            "section": "Collagenase susceptibility assay"
        },
        {
            "text": "Collagenase was added to the sample in a final enzymic activity of 100 units/mL for digestion at 37\u00b0C for up to 16 h. ",
            "section": "Collagenase susceptibility assay"
        },
        {
            "text": "After digestion, samples were centrifuged, washed with distilled water, and freeze-dried. ",
            "section": "Collagenase susceptibility assay"
        },
        {
            "text": "The resistance of tissue matrix to collagenase digestion was determined according to the dry mass of remaining tissue.",
            "section": "Collagenase susceptibility assay"
        },
        {
            "text": "The study was performed in strict compliance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health and other appropriated laws, as listed in the ethics statement above. ",
            "section": "In vivo biological response study with nonhuman primates",
            "entity_spans": [
                {
                    "type": "software",
                    "start": 77,
                    "end": 82,
                    "rawForm": "Guide",
                    "resp": "whitelist",
                    "id": "c1808df466-software-simple-w6"
                }
            ]
        },
        {
            "text": "The surgical procedure of abdominal wall repair according to Xu et al., 21 and the study protocol were approved by the IACUC, the Behavioral Sciences Foundation (St Kitts, Eastern Caribbean). ",
            "section": "In vivo biological response study with nonhuman primates",
            "ref_spans": [
                {
                    "start": 72,
                    "end": 74,
                    "type": "bibr",
                    "ref_id": "b20",
                    "text": "21"
                }
            ],
            "entity_spans": [
                {
                    "type": "software",
                    "start": 150,
                    "end": 160,
                    "rawForm": "Foundation",
                    "resp": "whitelist",
                    "id": "c1808df466-software-simple-w7"
                }
            ]
        },
        {
            "text": "All procedures used in this study, including surgical procedure, housing conditions, feeding regimens, and environmental enrichment, have been designed to alleviate suffering and to avoid discomfort, distress, and pain to the animals. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "Monkeys were housed at the test facility in a way such that they maintained visual contact with other monkeys at all times, and kept outdoors in individual American Association for Accreditation of Laboratory Animal Care (AAALAC)-approved cages, protected from weather extremes and subject to the normal temperature and humidity levels to which the monkeys were accustomed in order to decrease external stress factors. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "They were fed with 20% Harlan 2050 (Harlan Laboratories, Indianopolis, IN) Teklad Global 20% Protein Primate Diet supplemented with fresh fruits and vegetables. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "Water was provided ad libitum via water bottles. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "Cages were cleaned and maintained on a daily basis per standard procedure at the animal care facility. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "The monkeys were monitored by the technical staff for any conditions requiring possible veterinary care. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "Animals selected for surgery received supplements for enrichment such as produce treats and bamboo branches. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "Tactile and sensory enrichment was provided in the form of puzzle feeders, which rotated around the colony. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "Any aspects of this study that might cause more than momentary or slight pain or distress to the animals was performed with appropriate sedatives, analgesics, or anesthetics. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "Animals that experienced severe or chronic pain or distress that could not be relieved were painlessly euthanized as deemed appropriate by the test facility's veterinarian. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "Additional detailed information has been provided as supplemental support information.",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "Adult male vervet monkeys (Chlorocebus aethiops), 3-6 kg, were screened for general health, and quarantined for 2 weeks before surgery. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "The monkeys were fasted for 24 h prior to the surgical procedure, and each animal was given an injection of ketamine HCl 40-60 mg intramuscularly (IM) as a pre-anesthetic to allow the technician to safely handle the monkey prior to transportation to the procedure room. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "Each monkey received an injection of cefazolin sodium 125 mg IM (antibiotics) on the day of surgery. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "An intravenous (IV) catheter was placed in the monkey in order to provide access for IV fluids, which was maintained at a slow drip rate to keep the IV catheter patent and to assist flushing the line following IV injections. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "Just prior to the final preparation of the surgical site, the animal was given a combination of ketamine (10 mg/kg) and xylazine (1 mg/kg) IM. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "Additional ketamine/xylazine was given as needed throughout the procedure to maintain proper levels of anesthesia. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "For surgical implantation of a test material, a 3 cm \u00d7 7 cm full-thickness defect was created in the abdominal wall by removing the fascia, rectus muscle, and peritoneum. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "The defect was repaired with a test scaffold by tissue approximation to the defect edge and fixation using 3-0 polypropylene sutures. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "The area was draped using sterile drapes. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "Following the procedure, the monkeys were allowed to recover under the observation of a staff member, and were treated as necessary in order to assure a complete and uncomplicated recovery. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "Monkeys also received the analgesic drug flunixin meglumine at approximately 2.0-5.0 mg/kg IM or buprenorphine at 0.01 mg/kg subcutaneously (SC) or IM either prior to the surgical procedure or immediately following surgery. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "Additional administration was allowed twice daily for 3 days or longer depending on signs of pain as determined by the facility veterinarian.",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "Strattice, Veritas, and XenMatrix were investigated at 1-, 3-, and 6-month time points, with three animals euthanized for each test material per time point. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "The gross assessment of repairs was made for herniation or bulging in animals over the course of implantation. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "On the day of termination, the monkeys were given an injection of ketamine HCl 40-60 mg IM to allow the technician to safely handle the monkey prior to transportation to the necropsy room. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "Additional ketamine was given as needed throughout the procedure to maintain proper levels of anesthesia while drawing blood and performing the pre-explantation physical exam. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "After animals were sacrificed, explanted grafts were examined for scaffold integration with adjacent host tissue, and the possible presence of graft defect or hardening. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "The sizes of explanted scaffolds were measured, and percentage of graft contraction after implantation was calculated. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "Explanted samples were fixed in 10% buffered formalin solution for histological analysis as described earlier. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "Tissue sections from the center and interface of each graft material were stained with H&E. ",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "Histological evaluation was done by blinded assessment for host cell infiltration, revascularization, inflammatory response, and collagen remodeling.",
            "section": "In vivo biological response study with nonhuman primates"
        },
        {
            "text": "Blood samples were taken after implantation at various time points up to 6 months. ",
            "section": "Antibody determination after material implantation"
        },
        {
            "text": "Serum was tested for the presence of elevated antibodies reacting to implanted scaffolds (immunoglobulin G, IgG). ",
            "section": "Antibody determination after material implantation"
        },
        {
            "text": "Pre-implant samples were rinsed with 0.9% saline, freeze-dried, and micronized using a cryo-mill with liquid nitrogen. ",
            "section": "Antibody determination after material implantation"
        },
        {
            "text": "Micronized tissue powder was suspended in PBS, which was used to coat Immulon 96-well polystyrene microtiter plates (Thermo Fisher Scientific, Waltham, MA) by air-drying overnight. ",
            "section": "Antibody determination after material implantation"
        },
        {
            "text": "Serial dilutions of serum samples were incubated in the coated microtiter wells for 2 h. ",
            "section": "Antibody determination after material implantation"
        },
        {
            "text": "Plates were then washed and incubated for 1 h with goat anti-human IgG conjugated to alkaline phosphatase. ",
            "section": "Antibody determination after material implantation"
        },
        {
            "text": "Plates were rinsed and incubated with p-nitrophenyl phosphate substrate for 1 h for detection. ",
            "section": "Antibody determination after material implantation"
        },
        {
            "text": "Reaction product was measured at 405 nm in a plate reader, and the increase in antibody titer was determined according to the serial dilution curve.",
            "section": "Antibody determination after material implantation"
        },
        {
            "text": "The matrix structures of three scaffolds vary significantly ( Figure 1). ",
            "section": "Structural differences in scaffolds",
            "ref_spans": [
                {
                    "start": 62,
                    "end": 70,
                    "type": "figure",
                    "ref_id": "fig_0",
                    "text": "Figure 1"
                }
            ]
        },
        {
            "text": "Both Strattice and XenMatrix are derived from porcine dermis with proprietary processing technologies. ",
            "section": "Structural differences in scaffolds"
        },
        {
            "text": "On histological examination as compared with unprocessed porcine dermis (supplemental Figure S1), the structural integrity of native dermis ECM is retained in Strattice with a uniform architecture of intact collagen bundle structures and the absence of cells. ",
            "section": "Structural differences in scaffolds",
            "ref_spans": [
                {
                    "start": 86,
                    "end": 95,
                    "type": "figure",
                    "ref_id": "fig_0",
                    "text": "Figure S1"
                }
            ]
        },
        {
            "text": "XenMatrix comprises an altered dermal matrix that shows structural dissimilarity from native dermal ECM. ",
            "section": "Structural differences in scaffolds"
        },
        {
            "text": "Collagen bundles in XenMatrix are fragmented and largely separated. ",
            "section": "Structural differences in scaffolds"
        },
        {
            "text": "The matrix of pericardium-derived Veritas has a diffuse appearance that lacks the well-defined structural features in unprocessed pericardial ECM. ",
            "section": "Structural differences in scaffolds"
        },
        {
            "text": "On SEM examination, micrographs reveal more microscopic structural differences among the three scaffolds ( Figure 2). ",
            "section": "Structural differences in scaffolds",
            "ref_spans": [
                {
                    "start": 107,
                    "end": 115,
                    "type": "figure",
                    "ref_id": "fig_1",
                    "text": "Figure 2"
                }
            ]
        },
        {
            "text": "Strattice appears as a tightly intertwined and/or interwoven scaffold of collagen bundles, the fibrillar ultra-structures of which are preserved at fibril and fiber levels. ",
            "section": "Structural differences in scaffolds"
        },
        {
            "text": "Large pores over 50 \u00b5m are few between collagen bundles, and are mostly void spaces of blood vessels or removed hair follicles. ",
            "section": "Structural differences in scaffolds"
        },
        {
            "text": "XenMatrix does not show the architecture of porcine dermal ECM. ",
            "section": "Structural differences in scaffolds"
        },
        {
            "text": "Collagen fibrils and fibers in XenMatrix are fused together, leading to the complete loss of fibrillar ultra-structures of collagen bundles. ",
            "section": "Structural differences in scaffolds"
        },
        {
            "text": "Collagen bundles of XenMatrix are condensed, resulting in the formation of many large pores within the matrix. ",
            "section": "Structural differences in scaffolds"
        },
        {
            "text": "Veritas shows a very loose scaffold of collagen bundles, and large pores over 50 \u00b5m are abundant. ",
            "section": "Structural differences in scaffolds"
        },
        {
            "text": "The fibrillar ultra-structures of collagen bundles in Veritas are also preserved at fibril and fiber levels.",
            "section": "Structural differences in scaffolds"
        },
        {
            "text": "The DSC thermogram of fresh porcine dermis consists of multiple overlapping endothermic peaks between 20\u00b0C and 120\u00b0C ( Figure 3). ",
            "section": "Differences in calorimetric characteristics",
            "ref_spans": [
                {
                    "start": 119,
                    "end": 128,
                    "type": "figure",
                    "ref_id": "fig_2",
                    "text": "Figure 3)"
                }
            ]
        },
        {
            "text": "Upon heating at a scan rate of 3\u00b0C/min, protein denaturation starts at 54.0\u00b0C \u00b1 0.2\u00b0C, and the event ends when temperature reaches around 90\u00b0C, with a total enthalpic value of 54.8 \u00b1 2.4 J/g (n = 9). ",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "The complex thermogram of unprocessed porcine dermis consists of three separate denaturation events (Peaks A, B, and C), which account for 16.7% \u00b1 3.0%, 41.1% \u00b1 4.8%, and 42.2% \u00b1 4.0%, respectively (supplemental Figure S2). ",
            "section": "Differences in calorimetric characteristics",
            "ref_spans": [
                {
                    "start": 212,
                    "end": 222,
                    "type": "figure",
                    "ref_id": "fig_1",
                    "text": "Figure S2)"
                }
            ]
        },
        {
            "text": "Peak A disappears after cell lysis and washing in saline or PBS. ",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "The pd-ECM retains Peaks B and C, without any change in their onset and peak temperatures. ",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "The DSC thermogram of fresh bovine pericardium starts at a much higher temperature, 63.0\u00b0C \u00b1 0.5\u00b0C, with a smaller enthalpic value of 45.6 \u00b1 4.4 J/g (n = 10) ( Figure 3). ",
            "section": "Differences in calorimetric characteristics",
            "ref_spans": [
                {
                    "start": 160,
                    "end": 168,
                    "type": "figure",
                    "ref_id": "fig_2",
                    "text": "Figure 3"
                }
            ]
        },
        {
            "text": "It appears that the thermogram of bovine pericardium consists of only Peaks B and C between 20\u00b0C and 120\u00b0C, and Peak A in the lower temperature region is insignificant. ",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "The minimally processed bovine pericardial ECM has essentially the same DSC thermogram as fresh bovine pericardium (data not shown).",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "Commercially available scaffolds have calorimetric thermograms that are different from those of their respective unprocessed and/or minimally processed materials (Figure 4). ",
            "section": "Differences in calorimetric characteristics",
            "ref_spans": [
                {
                    "start": 162,
                    "end": 171,
                    "type": "figure",
                    "ref_id": "fig_3",
                    "text": "(Figure 4"
                }
            ]
        },
        {
            "text": "Thermograms of these scaffolds consist of two denaturation peaks, one with a peak width of about 10\u00b0C followed by a very broad peak with a width about 40\u00b0C. ",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "For Strattice and XenMatrix, Peak A is no longer present in finished scaffolds. ",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "Peaks B and C at the higher temperature region are still retained in finished scaffolds; however, the changes in denaturation temperature and curve shape (as compared to unprocessed dermis and minimally processed dermis) have demonstrated ECM alterations upon tissue processing (Figures 3 and 4). ",
            "section": "Differences in calorimetric characteristics",
            "ref_spans": [
                {
                    "start": 278,
                    "end": 295,
                    "type": "figure",
                    "ref_id": "fig_2",
                    "text": "(Figures 3 and 4)"
                }
            ]
        },
        {
            "text": "Strattice has an onset denaturation temperature of 55.5\u00b0C \u00b1 0.2\u00b0C, and an enthalpy of 56.6 \u00b1 6.7 J/g (n = 5). ",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "The onset denaturation temperature of XenMatrix is decreased to a lower temperature (48.3\u00b0C \u00b1 0.5\u00b0C, n = 6). ",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "There is no significant difference in enthalpy between Strattice and XenMatrix. ",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "The greatest change is observed in bovine pericardium-derived Veritas (Figures 3 and 4). ",
            "section": "Differences in calorimetric characteristics",
            "ref_spans": [
                {
                    "start": 70,
                    "end": 87,
                    "type": "figure",
                    "ref_id": "fig_2",
                    "text": "(Figures 3 and 4)"
                }
            ]
        },
        {
            "text": "The onset denaturation temperature of Veritas is decreased to 42.9\u00b0C \u00b1 0.2\u00b0C, whereas the enthalpy is increased to 56.6 \u00b1 5.1 J/g (n = 3).   ",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "To investigate further the changes in ECM properties after tissue processing, three scaffold products are analyzed with scan rates varying from 0.02\u00b0C/min to 50\u00b0C/min, which correspond to a change in time scale over three orders of magnitude ( Figure 5(a)). ",
            "section": "Differences in calorimetric characteristics",
            "ref_spans": [
                {
                    "start": 244,
                    "end": 255,
                    "type": "figure",
                    "ref_id": "fig_4",
                    "text": "Figure 5(a)"
                }
            ]
        },
        {
            "text": "The onset denaturation temperature of all ECM samples decreases as the scan rate is reduced, which is consistent with collagen denaturation as an irreversible, time-dependent kinetic process. ",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "Minimally processed native ECMs (i.e. porcine dermis ECM and bovine pericardium ECM) have higher onset denaturation temperatures than the derived commercial scaffolds, indicating that all tissue-processing technologies resulted in modifications that destabilize scaffolds ( Figure 5(a)). ",
            "section": "Differences in calorimetric characteristics",
            "ref_spans": [
                {
                    "start": 274,
                    "end": 285,
                    "type": "figure",
                    "ref_id": "fig_4",
                    "text": "Figure 5(a)"
                }
            ]
        },
        {
            "text": "There are significant differences among three commercial scaffolds. ",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "The intrinsic onset denaturation temperature (extrapolated to a scan rate of 0.01\u00b0C/min) is 55\u00b0C for the pd-ECM. ",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "The intrinsic onset denaturation temperature is reduced to 51\u00b0C and 44\u00b0C for Strattice and XenMatrix, respectively. ",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "Although the onset denaturation temperature of bovine pericardial ECM is higher than that of porcine dermal ECM, the derived Veritas has the lowest intrinsic onset denaturation temperature (38\u00b0C) ( Figure  5(a)). ",
            "section": "Differences in calorimetric characteristics",
            "ref_spans": [
                {
                    "start": 198,
                    "end": 210,
                    "type": "figure",
                    "ref_id": "fig_4",
                    "text": "Figure  5(a)"
                }
            ]
        },
        {
            "text": "Note that significant modifications of extracellular matrices are observed in finished bioscaffold products when compared to unprocessed fresh tissues (see Figure 3). ",
            "section": "Differences in calorimetric characteristics",
            "ref_spans": [
                {
                    "start": 156,
                    "end": 164,
                    "type": "figure",
                    "ref_id": "fig_2",
                    "text": "Figure 3"
                }
            ]
        },
        {
            "text": "\u02dc1 1% ECM (between the onset and peak temperature).",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "The inset shows the method of calculating the duration of denaturation time.",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "ECM: extracellular matrix; pd-ECM: minimally processed porcine dermis ECM; bp-ECM: minimally processed bovine pericardium ECM; DSC: differential heating calorimetry.",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "Process-caused modification and destabilization are also assessed by calculating the rate of protein denaturation at different onset temperatures ( Figure 5(b)). ",
            "section": "Differences in calorimetric characteristics",
            "ref_spans": [
                {
                    "start": 148,
                    "end": 159,
                    "type": "figure",
                    "ref_id": "fig_4",
                    "text": "Figure 5(b)"
                }
            ]
        },
        {
            "text": "The least stable ECM proteins denature between the onset denaturation temperature and the first peak temperature during a calorimetric measurement. ",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "This portion accounts for 11.1% \u00b1 2.4% of the total ECM proteins, assuming that the differential enthalpy is proportional to the mass of denatured ECM proteins. ",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "The duration required to denature this portion of ECM proteins increased exponentially as temperature decreased. ",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "The ECM stability is in the order of bovine pericardial ECM > porcine dermal ECM > Strattice > XenMatrix > Veritas. ",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "The Veritas scaffold does not appear to be sufficiently stable at the human body temperature. ",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "Figure 6 compares the susceptibility to type I collagenase between commercially available scaffolds and their respective minimally processed ECM materials. ",
            "section": "Differences in calorimetric characteristics",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 8,
                    "type": "figure",
                    "ref_id": "fig_5",
                    "text": "Figure 6"
                }
            ]
        },
        {
            "text": "No significant difference is observed between Strattice scaffold and pd-ECM. ",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "Under the testing condition, the half-life is measured to be 8.9 \u00b1 0.8 h (n = 6) and 8.5 \u00b1 1.1 h (n = 5) for Strattice and pd-ECM, respectively. ",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "These values are similar to that of the fresh porcine skin material (8.9 \u00b1 1.2 h, n = 7). ",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "The susceptibility of XenMatrix to type I collagenase is increased, with its half-life reduced to 4.8 \u00b1 0.5 h (n = 3). ",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "The difference in the susceptibility to type I collagenase between Strattice and XenMatrix is statistically significant (p = 0.0001). ",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "The susceptibility of bovine pericardium ECM to type I collagenase is higher than porcine dermis ECM, possibly due to the fact that bovine pericardium is thinner and less dense than porcine dermis. ",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "The half-life of bp-ECM is 5.5 \u00b1 0.6 h (n = 3). ",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "Veritas is the most susceptible to type I collagenase, with a half-life of 1.1 \u00b1 0.3 h (n = 2), and about 80% is degraded within 2 h of incubation at 37\u00b0C.",
            "section": "Differences in calorimetric characteristics"
        },
        {
            "text": "In vivo evaluation using the abdominal wall repair primate model has demonstrated that three scaffold products exhibit distinctively different biological responses in soft tissue repair. ",
            "section": "Differences in biological responses"
        },
        {
            "text": "All animals survived to the designated sacrifice date, with no herniation or bulging reported in any animals over the course of implantation. ",
            "section": "Differences in biological responses"
        },
        {
            "text": "Gross evaluation of explanted grafts reveals no defect or graft hardening and shows good integration with adjacent host tissue for Strattice grafts. ",
            "section": "Differences in biological responses"
        },
        {
            "text": "XenMatrix grafts show graft hardening and are less well integrated with surrounding host tissue at the 1-month and 3-month time points. ",
            "section": "Differences in biological responses"
        },
        {
            "text": "Veritas-explanted grafts are much smaller than the pre-implants, indicating in vivo graft contraction. ",
            "section": "Differences in biological responses"
        },
        {
            "text": "The size of Veritas grafts is reduced by \u02dc6 0%, whereas the size of Strattice and XenMatrix grafts is reduced by \u02dc2 0%-30% ( Figure 7). ",
            "section": "Differences in biological responses",
            "ref_spans": [
                {
                    "start": 125,
                    "end": 134,
                    "type": "figure",
                    "ref_id": "fig_6",
                    "text": "Figure 7)"
                }
            ]
        },
        {
            "text": "Histological evaluation demonstrates that Strattice is rapidly repopulated with host  cells, and gradually remodeled over a period of 6 months, as indicated by new collagen deposition. ",
            "section": "Differences in biological responses"
        },
        {
            "text": "Strattice results in minimal inflammatory response at the 1-month time point (Figure 8(a)-",
            "section": "Differences in biological responses",
            "ref_spans": [
                {
                    "start": 77,
                    "end": 86,
                    "type": "figure",
                    "ref_id": "fig_8",
                    "text": "(Figure 8"
                }
            ]
        },
        {
            "text": "(c)). ",
            "section": "Differences in biological responses"
        },
        {
            "text": "Veritas scaffold condensed and fused after 1-month of implantation into the primate, and lacked histological collagen structure as seen in the Veritas preimplant ( Figures 1 and 8(d)). ",
            "section": "Differences in biological responses",
            "ref_spans": [
                {
                    "start": 164,
                    "end": 182,
                    "type": "figure",
                    "ref_id": "fig_0",
                    "text": "Figures 1 and 8(d)"
                }
            ]
        },
        {
            "text": "Host cell infiltration of Veritas grafts is limited to peripheral at the 1-month time point, and thus, the most graft area remains acellular. ",
            "section": "Differences in biological responses"
        },
        {
            "text": "At the 3-and 6-month time points, cell in-growth is stimulated. ",
            "section": "Differences in biological responses"
        },
        {
            "text": "The implanted Veritas is difficult to be identified at the 3-month time point and appears to be completely absorbed with new collagen deposition observed at the implantation site. ",
            "section": "Differences in biological responses"
        },
        {
            "text": "The implantation of Veritas results in moderate inflammation at the 1-month time point, and the inflammatory response lessens as the Veritas material is rapidly absorbed (Figure  8",
            "section": "Differences in biological responses",
            "ref_spans": [
                {
                    "start": 170,
                    "end": 180,
                    "type": "figure",
                    "ref_id": "fig_8",
                    "text": "(Figure  8"
                }
            ]
        },
        {
            "text": "(e) and ",
            "section": "Differences in biological responses"
        },
        {
            "text": "(f)). ",
            "section": "Differences in biological responses"
        },
        {
            "text": "Implanted XenMatrix has demonstrated limited host cell in-growth at the 1-month time point, with host cells (including fibroblasts and macrophages) being able to get into the large pores only. ",
            "section": "Differences in biological responses"
        },
        {
            "text": "Despite XenMatrix possessing the highest porosity among three scaffold products ( Figures  1 and 8(g) to ",
            "section": "Differences in biological responses",
            "ref_spans": [
                {
                    "start": 82,
                    "end": 101,
                    "type": "figure",
                    "ref_id": "fig_0",
                    "text": "Figures  1 and 8(g)"
                }
            ]
        },
        {
            "text": "(i)), acellular areas are still observed at the 3and 6-month time points (Figure 8(h) and ",
            "section": "Differences in biological responses",
            "ref_spans": [
                {
                    "start": 73,
                    "end": 85,
                    "type": "figure",
                    "ref_id": "fig_8",
                    "text": "(Figure 8(h)"
                }
            ]
        },
        {
            "text": "(i)). ",
            "section": "Differences in biological responses"
        },
        {
            "text": "Cell ingrowth and new collagen deposition at the later time points occur at the slowly degraded and eroded scaffold areas. ",
            "section": "Differences in biological responses"
        },
        {
            "text": "XenMatrix induces severe inflammation at all three time points, as demonstrated by the presence of numerous macrophages and foreign-body giant cells. ",
            "section": "Differences in biological responses"
        },
        {
            "text": "Figure 9 shows the elevation of systemic antibody (IgG) titer in animal serum in response to implanted scaffolds. ",
            "section": "Differences in biological responses",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 8,
                    "type": "figure",
                    "ref_id": "fig_9",
                    "text": "Figure 9"
                }
            ]
        },
        {
            "text": "Strattice results in the high IgG level initially (\u02dc100-fold increase), and the IgG titer gradually diminishes thereafter. ",
            "section": "Differences in biological responses"
        },
        {
            "text": "Animals with implanted Veritas only had a small transient increase in the IgG titer during the first month, which returned to baseline level thereafter. ",
            "section": "Differences in biological responses"
        },
        {
            "text": "XenMatrix also elevates the level of IgG titer in animals by \u02dc100-folds. ",
            "section": "Differences in biological responses"
        },
        {
            "text": "Unlike Strattice, however, the high IgG level in animals with implanted XenMatrix remains unchanged for the entire experiment period (6 months), indicating a sustained humoral immune response.",
            "section": "Differences in biological responses"
        },
        {
            "text": "This study aims to examine the relationship between ECM modifications by processing methods and the mechanisms of action in soft tissue repair and regeneration in vivo. ",
            "section": "Discussion and conclusion"
        },
        {
            "text": "Three commercially available scaffolds (Strattice, Veritas and XenMatrix) were selected for comparison for the following reasons. ",
            "section": "Discussion and conclusion"
        },
        {
            "text": "Tissue-processing methods for medical devices are validated to produce scaffolds of consistent quality. ",
            "section": "Discussion and conclusion"
        },
        {
            "text": "All three ECM scaffolds are non-cross-linked, packaged in the hydrated state, and terminally sterilized by e-beam irradiation. ",
            "section": "Discussion and conclusion"
        },
        {
            "text": "As a result, scaffold modifications are attributed mainly to tissue origin, process treatments for decellularization, and antigenicity reduction. ",
            "section": "Discussion and conclusion"
        },
        {
            "text": "The performance of these scaffold products in human patients has been documented, 12,[38][39][40][41][42] and therefore, such a study could offer valuable biochemical and structural insights for the rational design of tissue engineering scaffolds for applications in human patients. ",
            "section": "Discussion and conclusion",
            "ref_spans": [
                {
                    "start": 82,
                    "end": 85,
                    "type": "bibr",
                    "ref_id": "b11",
                    "text": "12,"
                },
                {
                    "start": 85,
                    "end": 89,
                    "type": "bibr",
                    "ref_id": "b37",
                    "text": "[38]"
                },
                {
                    "start": 89,
                    "end": 93,
                    "type": "bibr",
                    "ref_id": "b38",
                    "text": "[39]"
                },
                {
                    "start": 93,
                    "end": 97,
                    "type": "bibr",
                    "ref_id": "b39",
                    "text": "[40]"
                },
                {
                    "start": 97,
                    "end": 101,
                    "type": "bibr",
                    "ref_id": "b40",
                    "text": "[41]"
                },
                {
                    "start": 101,
                    "end": 105,
                    "type": "bibr",
                    "ref_id": "b41",
                    "text": "[42]"
                }
            ]
        },
        {
            "text": "In this study, we followed a previously described methodology that chooses in vitro ECM tests and in vivo animal models for evaluating the performance of ECM scaffolds. ",
            "section": "Discussion and conclusion"
        },
        {
            "text": "43 Three-dimensional structural properties of scaffolds are known to play critical roles in supporting new tissue formation via in situ cell repopulation and revascularization that ultimately lead to the remodeling of the ECM scaffold into a functional tissue. ",
            "section": "Discussion and conclusion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 2,
                    "type": "bibr",
                    "ref_id": "b42",
                    "text": "43"
                }
            ]
        },
        {
            "text": "Processing methods alter scaffold structures differently (Figures 1 and 2). ",
            "section": "Discussion and conclusion",
            "ref_spans": [
                {
                    "start": 57,
                    "end": 74,
                    "type": "figure",
                    "ref_id": "fig_0",
                    "text": "(Figures 1 and 2)"
                }
            ],
            "entity_spans": [
                {
                    "type": "software",
                    "start": 0,
                    "end": 10,
                    "rawForm": "Processing",
                    "resp": "whitelist",
                    "id": "c1808df466-software-simple-w8"
                }
            ]
        },
        {
            "text": "The Strattice process causes no or little visible structural modification, yielding an ECM scaffold with microscopic architecture and ultrastructural features similar to that of a native porcine dermis (supplemental Figure S1). ",
            "section": "Discussion and conclusion",
            "ref_spans": [
                {
                    "start": 216,
                    "end": 226,
                    "type": "figure",
                    "ref_id": "fig_0",
                    "text": "Figure S1)"
                }
            ]
        },
        {
            "text": "In contrast, the XenMatrix process yields a substantially altered scaffold with few structural similarities to native dermal ECM. ",
            "section": "Discussion and conclusion"
        },
        {
            "text": "In vivo evaluation using the non-human primate model demonstrates a rapid fibroblast repopulation into Strattice ECM that is gradually remodeled (Figure 8(a)-(c)). ",
            "section": "Discussion and conclusion",
            "ref_spans": [
                {
                    "start": 145,
                    "end": 154,
                    "type": "figure",
                    "ref_id": "fig_8",
                    "text": "(Figure 8"
                }
            ]
        },
        {
            "text": "Cell in-growth is limited in XenMatrix at the 1-month time point, despite the XenMatrix process being intentionally designed to loosen collagen network to increase the scaffold porosity for earlier cell repopulation, 33 and indeed, the XenMatrix scaffold has significantly more large pores than both native dermis and Strattice scaffold ( Figures 1, 2 and supplemental Figure  S1). ",
            "section": "Discussion and conclusion",
            "ref_spans": [
                {
                    "start": 217,
                    "end": 219,
                    "type": "bibr",
                    "ref_id": "b32",
                    "text": "33"
                },
                {
                    "start": 339,
                    "end": 351,
                    "type": "figure",
                    "ref_id": "fig_0",
                    "text": "Figures 1, 2"
                },
                {
                    "start": 369,
                    "end": 379,
                    "type": "figure",
                    "ref_id": "fig_0",
                    "text": "Figure  S1"
                }
            ]
        },
        {
            "text": "The XenMatrix process results in the loss of fibrillar ultrastructural features of collagen bundles due to the condensation of collagen fibrils and fibers. ",
            "section": "Discussion and conclusion"
        },
        {
            "text": "Microscopic and ultrastructural features in scaffolds affect cell adhesion and migration. ",
            "section": "Discussion and conclusion"
        },
        {
            "text": "[44][45][46] The collagen structural damage by the XenMatrix process appears to outweigh the potential benefit of the increased scaffold porosity. ",
            "section": "Discussion and conclusion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 4,
                    "type": "bibr",
                    "ref_id": "b43",
                    "text": "[44]"
                },
                {
                    "start": 4,
                    "end": 8,
                    "type": "bibr",
                    "ref_id": "b44",
                    "text": "[45]"
                },
                {
                    "start": 8,
                    "end": 12,
                    "type": "bibr",
                    "ref_id": "b45",
                    "text": "[46]"
                }
            ]
        },
        {
            "text": "Even at the 3-and 6-month time points (Figure 8(h) and ",
            "section": "Discussion and conclusion",
            "ref_spans": [
                {
                    "start": 38,
                    "end": 50,
                    "type": "figure",
                    "ref_id": "fig_8",
                    "text": "(Figure 8(h)"
                }
            ]
        },
        {
            "text": "(i)), acellular areas are still observed, and cell in-growth in XenMatrix is associated with slowly degraded areas. ",
            "section": "Discussion and conclusion"
        },
        {
            "text": "The Veritas process results in some matrix modifications, but fibrillar ultrastructures of collagen bundles are still preserved (Figures 1  and 2, supplemental Figure S1). ",
            "section": "Discussion and conclusion",
            "ref_spans": [
                {
                    "start": 128,
                    "end": 145,
                    "type": "figure",
                    "ref_id": "fig_0",
                    "text": "(Figures 1  and 2"
                },
                {
                    "start": 160,
                    "end": 169,
                    "type": "figure",
                    "ref_id": "fig_0",
                    "text": "Figure S1"
                }
            ]
        },
        {
            "text": "Cell in-growth into the Veritas scaffold is limited to the periphery at the 1-month time point (Figure 8 Calorimetric analysis measures the changes in the thermophysical and thermochemical integrity of ECM scaffolds (e.g. structural destabilization, degradation, partial denaturation and cross-linking). ",
            "section": "Discussion and conclusion",
            "ref_spans": [
                {
                    "start": 95,
                    "end": 104,
                    "type": "figure",
                    "ref_id": "fig_8",
                    "text": "(Figure 8"
                }
            ]
        },
        {
            "text": "The thermal denaturation profile of an ECM scaffold depends not only on the stability of its individual constituent proteins, but also on the supramolecular assembly of these proteins (i.e. fibrogenesis, fiber alignment, and deposition of non-collagen materials)-the process to form a stable tissue matrix with unstable molecules. ",
            "section": "Discussion and conclusion"
        },
        {
            "text": "47,48 Calorimetric analysis shows that all three scaffold products are less stable than ECMs of their respective source tissues, demonstrating that processing treatments result in various degrees of ECM destabilization (Figure 4). ",
            "section": "Discussion and conclusion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 3,
                    "type": "bibr",
                    "ref_id": "b46",
                    "text": "47,"
                },
                {
                    "start": 3,
                    "end": 5,
                    "type": "bibr",
                    "ref_id": "b47",
                    "text": "48"
                },
                {
                    "start": 219,
                    "end": 228,
                    "type": "figure",
                    "ref_id": "fig_3",
                    "text": "(Figure 4"
                }
            ]
        },
        {
            "text": "The intrinsic matrix denaturation temperature is determined to be 51\u00b0C, 38\u00b0C, and 44\u00b0C for Strattice, Veritas, and XenMatrix, respectively ( Figure 5). ",
            "section": "Discussion and conclusion",
            "ref_spans": [
                {
                    "start": 141,
                    "end": 149,
                    "type": "figure",
                    "ref_id": "fig_4",
                    "text": "Figure 5"
                }
            ]
        },
        {
            "text": "This intrinsic denaturation temperature is extrapolated to a scan rate of 0.01\u00b0C/ min, corresponding to the duration of \u02dc2 days for complete denaturation at the intrinsic denaturation temperature. ",
            "section": "Discussion and conclusion"
        },
        {
            "text": "The intrinsic denaturation temperature is 55\u00b0C for porcine dermal ECM. ",
            "section": "Discussion and conclusion"
        },
        {
            "text": "The Strattice process causes a moderate decrease by 4\u00b0C, whereas the XenMatrix process results in a decrease of 11\u00b0C. ",
            "section": "Discussion and conclusion"
        },
        {
            "text": "Nevertheless, XenMatrix is still stable at human body temperature. ",
            "section": "Discussion and conclusion"
        },
        {
            "text": "The Veritas scaffold with an intrinsic temperature of 38\u00b0C is not stable at human body temperature. ",
            "section": "Discussion and conclusion"
        },
        {
            "text": "It is conceivable that, upon implantation, the Veritas scaffold would denature spontaneously over a few days or weeks. ",
            "section": "Discussion and conclusion"
        },
        {
            "text": "We hypothesize that the instability of Veritas at body temperature could be the cause for structural condensation (Figure 8(d)) and limited cell in-growth at the peripheral region of the scaffold. ",
            "section": "Discussion and conclusion",
            "ref_spans": [
                {
                    "start": 114,
                    "end": 126,
                    "type": "figure",
                    "ref_id": "fig_8",
                    "text": "(Figure 8(d)"
                }
            ]
        },
        {
            "text": "The decrease in thermal stability of scaffolds correlates with the increased vulnerability to enzyme degradation. ",
            "section": "Discussion and conclusion"
        },
        {
            "text": "15,49,50 Significant differences exist in the susceptibility to collagenase among three scaffold products ( Figure 6). ",
            "section": "Discussion and conclusion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 3,
                    "type": "bibr",
                    "ref_id": "b14",
                    "text": "15,"
                },
                {
                    "start": 3,
                    "end": 6,
                    "type": "bibr",
                    "ref_id": "b48",
                    "text": "49,"
                },
                {
                    "start": 6,
                    "end": 8,
                    "type": "bibr",
                    "ref_id": "b49",
                    "text": "50"
                },
                {
                    "start": 108,
                    "end": 116,
                    "type": "figure",
                    "ref_id": "fig_5",
                    "text": "Figure 6"
                }
            ]
        },
        {
            "text": "Strattice has similar susceptibility to collagenase as fresh porcine dermis and minimally processed dermal ECM do. ",
            "section": "Discussion and conclusion"
        },
        {
            "text": "The susceptibility of the XenMatrix scaffold to collagenase is increased, as shown by the reduced half-life. ",
            "section": "Discussion and conclusion"
        },
        {
            "text": "The reduced half-life of the XenMatrix scaffold may be associated with the increased scaffold porosity by design as well as more severe matrix destabilization by tissue processing (as seen from calorimetric data). ",
            "section": "Discussion and conclusion"
        },
        {
            "text": "The Veritas process increases the susceptibility to collagenase even more than the XenMatrix process. ",
            "section": "Discussion and conclusion"
        },
        {
            "text": "The half-life of the Veritas scaffold to collagenase digestion is only \u02dc2 0% of the half-life of the minimally processed bovine pericardial ECM. ",
            "section": "Discussion and conclusion"
        },
        {
            "text": "Not surprisingly, the Veritas scaffold is rapidly absorbed upon implantation in primates (Figures 7 and 8).",
            "section": "Discussion and conclusion",
            "ref_spans": [
                {
                    "start": 89,
                    "end": 106,
                    "type": "figure",
                    "ref_id": "fig_6",
                    "text": "(Figures 7 and 8)"
                }
            ]
        },
        {
            "text": "De-convolution of the fresh porcine dermis calorimetric thermogram. ",
            "section": "Discussion and conclusion"
        },
        {
            "text": "The complex thermogram (A) are deconvoluted into individual peak components (B) using a mathematical software PeakFit (PeakFit 4.12, Systat Software, San Jose, CA), so that the changes of peak temperature and percentage area of individual components could be evaluated after tissue processing. ",
            "section": "Discussion and conclusion",
            "entity_spans": [
                {
                    "start": 110,
                    "end": 117,
                    "type": "software",
                    "rawForm": "PeakFit",
                    "resp": "#annotator4",
                    "used": true,
                    "id": "c1808df466-software-1"
                },
                {
                    "start": 127,
                    "end": 131,
                    "type": "version",
                    "rawForm": "4.12",
                    "resp": "#curator",
                    "id": "#c1808df466-software-1"
                },
                {
                    "start": 133,
                    "end": 148,
                    "type": "publisher",
                    "rawForm": "Systat Software",
                    "resp": "#curator",
                    "id": "#c1808df466-software-1"
                },
                {
                    "type": "software",
                    "start": 101,
                    "end": 109,
                    "rawForm": "software",
                    "resp": "whitelist",
                    "id": "c1808df466-software-simple-w9"
                },
                {
                    "type": "software",
                    "start": 110,
                    "end": 117,
                    "rawForm": "PeakFit",
                    "resp": "whitelist",
                    "id": "c1808df466-software-simple-w10"
                },
                {
                    "type": "software",
                    "start": 119,
                    "end": 126,
                    "rawForm": "PeakFit",
                    "resp": "whitelist",
                    "id": "c1808df466-software-simple-w11"
                },
                {
                    "type": "software",
                    "start": 133,
                    "end": 139,
                    "rawForm": "Systat",
                    "resp": "whitelist",
                    "id": "c1808df466-software-simple-w12"
                }
            ]
        },
        {
            "text": "Peak temperatures and their percent enthalpy values are mean \u00b1 standard deviation. ",
            "section": "Discussion and conclusion",
            "ref_spans": [
                {
                    "start": 53,
                    "end": 62,
                    "type": "figure",
                    "ref_id": "fig_8",
                    "text": "(Figure 8"
                }
            ]
        },
        {
            "text": "Peak A disappears after cell lysis in water and a wash in phosphate-buffered saline, suggesting its origin of cellular proteins and loosely bounded ECM proteins. ",
            "section": "Discussion and conclusion",
            "ref_spans": [
                {
                    "start": 68,
                    "end": 76,
                    "type": "figure",
                    "ref_id": "fig_8",
                    "text": "Figure 8"
                }
            ]
        },
        {
            "text": "Minimally processed porcine dermis ECM retains Peak B and Peak C, without any change in their onset and peak temperatures.",
            "section": "Discussion and conclusion",
            "ref_spans": [
                {
                    "start": 1,
                    "end": 11,
                    "type": "figure",
                    "ref_id": "fig_9",
                    "text": "(Figure 9)"
                }
            ]
        },
        {
            "text": "The above data and information is available online with this article.",
            "section": "Supporting information"
        },
        {
            "text": "W.Q.S., M.S., and H.X. conceived and designed the experiments; W.Q.S., H.X., and J.L. performed the experiments; W.Q.S., H.X., and M.S. analyzed the data; W.Q.S., H.X., and J.L. contributed reagents/materials/analysis tools; and W.Q.S. wrote the article.",
            "section": "Acknowledgments"
        },
        {
            "text": "All authors are paid employees of LifeCell Corporation when the study was performed. ",
            "section": "Declaration of conflicting interests"
        },
        {
            "text": "The authors declare that there is no other conflict of interest.",
            "section": "Declaration of conflicting interests"
        },
        {
            "text": "The research was supported by LifeCell Corporation, and received received no other specific grant from any funding agency in the public, commercial, or not-for-profit sectors.",
            "section": "Funding"
        }
    ]
}